Home/Filings/4/0000091440-25-000089
4//SEC Filing

PINCHUK NICHOLAS T 4

Accession 0000091440-25-000089

CIK 0000091440other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 5:55 PM ET

Size

44.6 KB

Accession

0000091440-25-000089

Insider Transaction Report

Form 4
Period: 2025-12-02
PINCHUK NICHOLAS T
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-02$138.03/sh+33,750$4,658,513848,970.802 total
  • Sale

    Common Stock

    2025-12-02$336.19/sh1,928$648,166847,042.802 total
  • Sale

    Common Stock

    2025-12-02$337.20/sh2,144$722,966844,898.802 total
  • Sale

    Common Stock

    2025-12-02$338.06/sh1,760$594,982843,138.802 total
  • Sale

    Common Stock

    2025-12-02$339.47/sh7,060$2,396,655836,078.802 total
  • Sale

    Common Stock

    2025-12-02$340.07/sh9,277$3,154,839826,801.802 total
  • Sale

    Common Stock

    2025-12-02$341.53/sh438$149,591826,363.802 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-12-0233,7500 total
    Exercise: $138.03Exp: 2026-02-11Common Stock (33,750 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    862.228
  • Stock Option (Right to Buy)

    Exercise: $168.70Exp: 2027-02-09Common Stock (135,000 underlying)
    135,000
  • Stock Option (Right to Buy)

    Exercise: $161.18Exp: 2028-02-15Common Stock (92,288 underlying)
    92,288
  • Stock Option (Right to Buy)

    Exercise: $155.92Exp: 2029-02-14Common Stock (83,059 underlying)
    83,059
  • Stock Option (Right to Buy)

    Exercise: $189.89Exp: 2031-02-11Common Stock (40,687 underlying)
    40,687
  • Stock Option (Right to Buy)

    Exercise: $211.67Exp: 2032-02-10Common Stock (32,286 underlying)
    32,286
  • Stock Option (Right to Buy)

    Exercise: $249.26From: 2024-02-09Exp: 2033-02-09Common Stock (24,295 underlying)
    24,295
  • Stock Option (Right to Buy)

    Exercise: $269.00From: 2025-02-15Exp: 2034-02-15Common Stock (23,710 underlying)
    23,710
  • Stock Option (Right to Buy)

    Exercise: $339.73From: 2026-02-13Exp: 2035-02-13Common Stock (18,925 underlying)
    18,925
  • Restricted Stock Units

    From: 2026-02-09Exp: 2026-02-09Common Stock (5,549 underlying)
    5,549
  • Restricted Stock Units

    From: 2027-02-15Exp: 2027-02-15Common Stock (5,114 underlying)
    5,114
  • Restricted Stock Units

    From: 2028-02-13Exp: 2028-02-13Common Stock (4,425 underlying)
    4,425
  • Performance Units

    Common Stock (16,645 underlying)
    16,645
  • Performance Units

    Common Stock (15,340 underlying)
    15,340
  • Performance Units

    Common Stock (13,275 underlying)
    13,275
  • Deferred Stock Units

    Common Stock (26,060.106 underlying)
    26,060.106
Footnotes (18)
  • [F1]The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024.
  • [F10]Option fully vested.
  • [F11]Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024.
  • [F12]Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
  • [F13]1 for 1.
  • [F14]The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
  • [F15]If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F16]If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F17]If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F18]Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
  • [F2]Includes 1.5127 shares acquired under a dividend reinvestment plan.
  • [F3]This transaction was executed in multiple trades at prices ranging from $335.71 to $336.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F4]his transaction was executed in multiple trades at prices ranging from $336.74 to $337.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F5]This transaction was executed in multiple trades at prices ranging from $337.78 to $338.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F6]This transaction was executed in multiple trades at prices ranging from $338.78 to $339.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F7]This transaction was executed in multiple trades at prices ranging from $339.78 to $340.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F8]This transaction was executed in multiple trades at prices ranging from $341.48 to $341.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F9]This information is based on a plan statement dated September 30, 2025.

Issuer

Snap-on Inc

CIK 0000091440

Entity typeother

Related Parties

1
  • filerCIK 0001246136

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 5:55 PM ET
Size
44.6 KB